Irinotecan in Treating Patients With Esophageal or Stomach Cancer
Public ClinicalTrials.gov record NCT00003748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase II Study of Irinotecan (CPT-11) in Adenocarcinoma of the Esophagus and Gastric Cardia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of irinotecan in treating patients who have esophageal or stomach cancer.
Study identification
- NCT ID
- NCT00003748
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 1998
- Primary completion
- May 31, 2000
- Completion
- Dec 31, 2004
- Last update posted
- Aug 2, 2020
1998 – 2005
United States locations
- U.S. sites
- 25
- U.S. states
- 2
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| St Jude Heritage Health Foundation | Fullerton | California | 92835 | — |
| Daniel Freeman Memorial Hospital | Inglewood | California | 90301 | — |
| UCLA - Antelope Valley Cancer Center | Lancaster | California | 93534 | — |
| Pacific Shores Medical Group | Long Beach | California | 90813 | — |
| Jonsson Comprehensive Cancer Center, UCLA | Los Angeles | California | 90095-1781 | — |
| Community Hospital of the Monterey Peninsula | Monterey | California | 93940 | — |
| Office of Jerome L. Rubin | Monterey | California | 93940 | — |
| Office of Eddie Hu, M.D. | Monterey Park | California | 91754 | — |
| Ventura County Hematology-Oncology Medical Group, Inc. | Oxnard | California | 93030 | — |
| Wilshire Oncology Medical Center | Pomona | California | 91767 | — |
| Salinas Valley Memorial Hospital | Salinas | California | 93901 | — |
| Cancer Center of Santa Barbara | Santa Barbara | California | 93105 | — |
| Sansum Medical Clinic | Santa Barbara | California | 93105 | — |
| James L. Poth, M.D., Michael Alexander, M.D., Inc. | Santa Cruz | California | 95065 | — |
| Marian Medical Center | Santa Maria | California | 93454 | — |
| Office of Marilou Terpenning | Santa Monica | California | 90404 | — |
| Office of Robert C. Klein | Santa Monica | California | 90404 | — |
| Dominican and Watsonville Community Hospital | Soquel | California | 95073 | — |
| Los Robles Regional Medical Center | Thousand Oaks | California | 91360 | — |
| Cancer Care Associates Medical Group | Torrance | California | 90505 | — |
| UCLA Cancer Center - Santa Clarita | Valencia | California | 91355 | — |
| Oncology Medical Center of North County | Vista | California | 92083 | — |
| Valley Hematology and Oncology | West Hills | California | 91307 | — |
| Cancer Care Consultants | Las Vegas | Nevada | 89119 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Gastric Cancer trials
Other public records listing Gastric Cancer. Sorted by last update posted; newest first. Not a recommendation.
- NCT03526835: A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors Recruiting
- NCT04069273: Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma Active, not recruiting
- NCT05208762: A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting
- NCT07705334: A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors Recruiting
- NCT06580002: Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial Recruiting
- NCT07529808: Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00003748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2020 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00003748 live on ClinicalTrials.gov.